Latest stories on RNAZ
Transcode Therapeutics presents Phase 1a clinical data for TTX-MC138 in tumors
The Fly58 · neutralproduct/pr
TransCode Therapeutics Presents Phase 1a Clinical Data for TTX-MC138 at ESMO Congress 2026
StockTitan58 · neutralproduct/pr
TransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026
PR Newswire58 · neutralproduct/pr
Natera, Transcode to collaborate on Phase 2a trial of TTX-MC138
The Fly63 · neutralproduct/pr
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
StockTitan63 · neutralproduct/pr
Transcode Therapeutics, Inc. (RNAZ) files 8-K
SEC 8-K50 · neutralgeneral
Transcode Therapeutics, Inc. (RNAZ) files 8-K
SEC 8-K50 · neutralgeneral
Transcode Therapeutics reports updated results from Phase 1a TTX-MC138 trial
The Fly59 · neutralproduct/pr
TransCode Therapeutics, Inc. (RNAZ) Discusses Advancing Multi-Platform Oncology Pipeline Targeting Metastatic Cancer Transcript
Seeking Alpha63 · neutralproduct/pr
Join Today's Live Investor Webinar with TransCode Therapeutics
Barchart55 · neutralgeneral
Transcode Therapeutics, Inc. (RNAZ) files 8-K
SEC 8-K50 · neutralgeneral
TransCode Therapeutics Taps Tattory to Be Interim CFO
MarketWatch55 · neutralgeneral
TransCode Therapeutics CFO retires
Seeking Alpha50 · neutralgeneral
Transcode Therapeutics CFO Fitzgerald retiring, Tattory named interim CFO
The Fly47 · neutralgeneral
TransCode Therapeutics Announces Leadership Transition
PR Newswire50 · neutralgeneral
Transcode Therapeutics announces publication of article on TTX-MC138
The Fly59 · neutralproduct/pr
TransCode Therapeutics Updates Preferred Stock Governance Terms
TipRanks50 · neutralgeneral
Transcode Therapeutics, Inc. (RNAZ) files 8-K
SEC 8-K50 · neutralgeneral
TransCode Therapeutics Shareholders Approve Key Capital Measures
TipRanks50 · neutralgeneral
Transcode Therapeutics, Inc. (RNAZ) files 8-K
SEC 8-K50 · neutralgeneral
TransCode Therapeutics Updates Preferred Stock Ownership Limits
TipRanks50 · neutralgeneral
Transcode Therapeutics, Inc. (RNAZ) files 8-K
SEC 8-K50 · neutralgeneral